Australian breast cancer innovators close $27M private funding round featuring OncoRes Medical
PERTH, Australia–(BUSINESS WIRE)–OncoRes Medical today announced it has closed an AUD $27M private funding round (‘the Funding round’) to progress clinical development and regulatory milestones for its Quantitative Micro-Elastography (QME) Imaging System, Elora™.
The Funding round included a cornerstone investment from Brandon Capital Partners’ BB6 Fund; significant investment from Morgans; Radar Ventures; Australian and international family offices and The Table Club network.
Elora™ provides real-time tumour assessment to help surgeons more accurately identify and remove cancerous tissue—an approach that could substantially improve outcomes in breast-conserving surgery (BCS) and reduce repeat operations for women with breast cancer. This technology uniquely enhances the surgeon’s sense of touch, enabling real-time, high-resolution intraoperative assessment of the tumour cavity.
